BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 18824881)

  • 1. Synchronous and metachronous extrapancreatic malignant neoplasms in patients with intraductal papillary-mucinous neoplasm of the pancreas.
    Ishida M; Egawa S; Kawaguchi K; Aoki T; Sakata N; Mikami Y; Motoi F; Abe T; Fukuyama S; Katayose Y; Sunamura M; Unno M; Moriya T; Horii A; Furukawa T
    Pancreatology; 2008; 8(6):577-82. PubMed ID: 18824881
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characteristic clinicopathological features of the types of intraductal papillary-mucinous neoplasms of the pancreas.
    Ishida M; Egawa S; Aoki T; Sakata N; Mikami Y; Motoi F; Abe T; Fukuyama S; Sunamura M; Unno M; Moriya T; Horii A; Furukawa T
    Pancreas; 2007 Nov; 35(4):348-52. PubMed ID: 18090241
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mural nodule in branch duct-type intraductal papillary mucinous neoplasms of the pancreas is a marker of malignant transformation and indication for surgery.
    Akita H; Takeda Y; Hoshino H; Wada H; Kobayashi S; Marubashi S; Eguchi H; Tanemura M; Mori M; Doki Y; Nagano H
    Am J Surg; 2011 Aug; 202(2):214-9. PubMed ID: 21376305
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extrapancreatic malignancies in patients with intraductal papillary mucinous neoplasm of the pancreas: prevalence, associated factors, and comparison with patients with other pancreatic cystic neoplasms.
    Yoon WJ; Ryu JK; Lee JK; Woo SM; Lee SH; Park JK; Kim YT; Yoon YB
    Ann Surg Oncol; 2008 Nov; 15(11):3193-8. PubMed ID: 18784959
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intraductal papillary-mucinous adenocarcinoma in the remnant pancreas after pancreatoduodenectomy for cancer of Vater's papilla associated with intraductal papillary-mucinous adenoma.
    Ishida M; Egawa S; Sakata N; Mikami Y; Motoi F; Abe T; Fukuyama S; Sunamura M; Furukawa T; Unno M
    J Hepatobiliary Pancreat Surg; 2007; 14(5):522-5. PubMed ID: 17909725
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MUC2 expression and prevalence of high-grade dysplasia and invasive carcinoma in mixed-type intraductal papillary mucinous neoplasm of the pancreas.
    Masuda A; Arisaka Y; Hara S; Matsumoto I; Takenaka M; Sakai A; Shiomi H; Matsuki N; Sugimoto M; Fujita T; Hayakumo T; Ku Y; Ogino S; Azuma T; Kutsumi H
    Pancreatology; 2013; 13(6):583-8. PubMed ID: 24280573
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Negative correlation between the nuclear size and nuclear Lamina component Lamin A in intraductal papillary mucinous neoplasms of the pancreas.
    Hiroe T; Moriya S; Kobayashi S; Nishijima Y; Watanabe A; Shirabe K; Ikota H; Yokoo H; Saio M
    Pathol Oncol Res; 2022; 28():1610684. PubMed ID: 36561231
    [No Abstract]   [Full Text] [Related]  

  • 8. Intraductal papillary mucinous neoplasm.
    Shi C; Hruban RH
    Hum Pathol; 2012 Jan; 43(1):1-16. PubMed ID: 21777948
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intraductal papillary-mucinous neoplasms of the gastric and intestinal types may have less malignant potential than the pancreatobiliary type.
    Takasu N; Kimura W; Moriya T; Hirai I; Takeshita A; Kamio Y; Nomura T
    Pancreas; 2010 Jul; 39(5):604-10. PubMed ID: 20124938
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patients with pancreatic intraductal papillary mucinous neoplasms are at high risk of colorectal cancer development.
    Eguchi H; Ishikawa O; Ohigashi H; Tomimaru Y; Sasaki Y; Yamada T; Tsukuma H; Nakaizumi A; Imaoka S
    Surgery; 2006 Jun; 139(6):749-54. PubMed ID: 16782429
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Minimally invasive intraductal papillary-mucinous carcinoma of the pancreas: clinicopathologic study of 104 intraductal papillary-mucinous neoplasms.
    Nara S; Shimada K; Kosuge T; Kanai Y; Hiraoka N
    Am J Surg Pathol; 2008 Feb; 32(2):243-55. PubMed ID: 18223327
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of histologic subtype and growth pattern in intraductal papillary-mucinous carcinoma of the pancreas.
    Sanada Y; Kunita S; Yoshida K
    Oncol Rep; 2008 Jun; 19(6):1435-43. PubMed ID: 18497948
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Frequency of subtypes of biliary intraductal papillary mucinous neoplasm and their MUC1, MUC2, and DPC4 expression patterns differ from pancreatic intraductal papillary mucinous neoplasm.
    Sclabas GM; Barton JG; Smyrk TC; Barrett DA; Khan S; Kendrick ML; Reid-Lombardo KM; Donohue JH; Nagorney DM; Que FG
    J Am Coll Surg; 2012 Jan; 214(1):27-32. PubMed ID: 22112419
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intraductal papillary mucinous neoplasm of the pancreas: associated cancers, family history, genetic predisposition?
    Lubezky N; Ben-Haim M; Lahat G; Marmor S; Solar I; Brazowski E; Nackache R; Klausner JM
    Surgery; 2012 Jan; 151(1):70-5. PubMed ID: 21975290
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic alterations in adenoma-carcinoma sequencing of intraductal papillary-mucinous neoplasm of the pancreas.
    Nakata B; Yashiro M; Nishioka N; Aya M; Yamada S; Takenaka C; Ohira M; Ishikawa T; Nishino H; Wakasa K; Hirakawa K
    Int J Oncol; 2002 Nov; 21(5):1067-72. PubMed ID: 12370756
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Invasive carcinoma derived from the nonintestinal type intraductal papillary mucinous neoplasm of the pancreas has a poorer prognosis than that derived from the intestinal type.
    Sadakari Y; Ohuchida K; Nakata K; Ohtsuka T; Aishima S; Takahata S; Nakamura M; Mizumoto K; Tanaka M
    Surgery; 2010 Jun; 147(6):812-7. PubMed ID: 20060146
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of ductal carcinoma of the pancreas during follow-up of branch duct intraductal papillary mucinous neoplasm of the pancreas.
    Uehara H; Nakaizumi A; Ishikawa O; Iishi H; Tatsumi K; Takakura R; Ishida T; Takano Y; Tanaka S; Takenaka A
    Gut; 2008 Nov; 57(11):1561-5. PubMed ID: 18477671
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinicopathologic characteristics of patients with resected multifocal intraductal papillary mucinous neoplasm of the pancreas.
    Fritz S; Schirren M; Klauss M; Bergmann F; Hackert T; Hartwig W; Strobel O; Grenacher L; Büchler MW; Werner J
    Surgery; 2012 Sep; 152(3 Suppl 1):S74-80. PubMed ID: 22770954
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence of synchronous and metachronous pancreatic carcinoma in 168 patients with branch duct intraductal papillary mucinous neoplasm.
    Tanno S; Nakano Y; Sugiyama Y; Nakamura K; Sasajima J; Koizumi K; Yamazaki M; Nishikawa T; Mizukami Y; Yanagawa N; Fujii T; Obara T; Okumura T; Kohgo Y
    Pancreatology; 2010; 10(2-3):173-8. PubMed ID: 20484955
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparison between intraductal papillary neoplasms of the biliary tract (BT-IPMNs) and intraductal papillary mucinous neoplasms of the pancreas (P-IPMNs) reveals distinct clinical manifestations and outcomes.
    Minagawa N; Sato N; Mori Y; Tamura T; Higure A; Yamaguchi K
    Eur J Surg Oncol; 2013 Jun; 39(6):554-8. PubMed ID: 23506840
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.